InvestorsHub Logo
Followers 835
Posts 120262
Boards Moderated 18
Alias Born 09/05/2002

Re: orangeone post# 3126

Friday, 05/06/2011 1:35:47 PM

Friday, May 06, 2011 1:35:47 PM

Post# of 20689
Rick Shea admitted on a webcast a few months ago that the Lovenox capacity constraint is deliberate and the rationale is to avert an authorized generic launch by SNY.

MNTA executives mention this capacity constraint prominently on many webcasts because they know people from SNY are listening in.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”